Exavir Therapeutics Completes $4M Seed Financing from Key Investors
May 23, 2022 07:00 ET
|
Exavir Therapeutics
NEW YORK and OMAHA, Neb., May 23, 2022 (GLOBE NEWSWIRE) -- Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that...
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 17, 2022 08:00 ET
|
QSAM Biosciences Inc.
Dosed First Patient in Phase 1 Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer Austin, TX, May 17, 2022 (GLOBE NEWSWIRE) -- QSAM...
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
February 17, 2022 17:42 ET
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
Global Healthcare Gamification Market Envisioned to Generate a Revenue of $47,281.5 Million by 2026 and Grow at a CAGR of 11.9% over the Estimated Timeframe from 2019-2026 [120-Pages] | Confirmed by Research Dive
January 03, 2022 09:00 ET
|
Research Dive
New York, USA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global healthcare gamification market is anticipated to generate a revenue of $47,281.5...
Global Healthcare Gamification Market Estimated to Surpass $47,281.5 Million by 2026, and Grow at a CAGR of 11.9% during the Forecast Period [120-Pages] | Divulge by Research Dive
December 21, 2021 09:00 ET
|
Research Dive
New York, USA, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global healthcare gamification market is estimated to garner a revenue of $47,281.5 million by 2026, and rise at a CAGR...
Oral Contraceptive Pills Market Report Up to 2031: Visiongain Research Inc
December 08, 2021 09:30 ET
|
Visiongain Ltd
Visiongain has published a new report on Oral Contraceptive Pills Market Report 2021-2031: Forecasts By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug...
Report from Incubate Policy Lab and Charles River Associates Finds Price Controls Would Decrease Investment in Critical Therapeutic Areas
November 18, 2021 17:08 ET
|
Incubate
Washington, D.C., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab and Charles River Associates published a report detailing how investment into therapies for rare diseases and oncology...
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
October 28, 2021 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced...
Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV
September 16, 2021 07:30 ET
|
Exavir Therapeutics
With a single administration, XVIR-210, a nano-formulated prodrug of tenofovir, provided drug levels sufficient for chronic HBV treatment, HIV treatment, and HIV prophylaxis for over two months in...
Global Healthcare Gamification Market Projected to Garner $47,281.5 Million Revenue by 2026, and Rise at a CAGR of 11.9% from 2019 to 2026 - Exclusive Report [120-Pages] by Research Dive
September 08, 2021 09:00 ET
|
Research Dive
New York, USA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global healthcare gamification market is anticipated to register a revenue of $47,281.5 million by 2026, at a CAGR of...